Inactive Instrument
Company Cognetivity Neurosciences Ltd. Canadian Securities Exchange
Stocks
CGN
CA19243C1005
Advanced Medical Equipment & Technology
Business description: Cognetivity Neurosciences Ltd.

Sales by Activity: Cognetivity Neurosciences Ltd.
| Fiscal Period: January | 2019 (CAD) | 2020 (CAD) | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) |
|---|---|---|---|---|---|
Development of The ICA Platform | - | - | - | - | 45.37K |
Geographical breakdown of sales: Cognetivity Neurosciences Ltd.
| Fiscal Period: January | 2019 (CAD) | 2020 (CAD) | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) |
|---|---|---|---|---|---|
United Kingdom | - | - | - | - | 45.37K |
Executive Committee: Cognetivity Neurosciences Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Habibi
CEO | Chief Executive Officer | 45 | 31/03/2013 |
Mark Phillips
CMP | Compliance Officer | 67 | 20/12/2017 |
Composition of the Board of Directors: Cognetivity Neurosciences Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Sina Habibi
BRD | Director/Board Member | 45 | 31/12/2016 |
Mark Phillips
BRD | Director/Board Member | 67 | 20/12/2017 |
Company details: Cognetivity Neurosciences Ltd.

Medical Software & Technology Services
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.52% | +2.50% | -28.66% | -5.72% | 31.97B | ||
| -3.34% | -8.75% | -39.34% | +193.63% | 14.42B | ||
| +1.42% | -2.52% | -20.49% | +73.05% | 5.7B | ||
| -2.10% | -3.50% | - | - | 2.26B | ||
| +3.92% | +3.18% | +62.70% | -36.39% | 2.12B | ||
| -0.31% | -15.60% | - | - | 1.83B | ||
| -1.91% | -2.80% | -31.22% | - | 1.09B | ||
| -2.81% | -6.14% | +47.16% | +105.51% | 922M | ||
| -0.94% | +0.78% | -33.39% | +252.82% | 821M | ||
| Average | -0.29% | -3.72% | -6.18% | +97.15% | 6.79B | |
| Weighted average by Cap. | +1.14% | -3.17% | -26.04% | +58.15% |

















